Alcohol consumption and the incidence of hyperuricemia in Japanese men and women Authors: Tamami Ueno, Kazumi Kawano, Chihiro Nohara, Kaori Maki, Kazuyo Iwanaga, Akiko Morinaga, Shunsuke Funakoshi, Makiko Abe, Atsushi Satoh, Miki Kawazoe, Toshiki Maeda, Chikara Yoshimura, Koji Takahashi, Kazuhiro Tada, Kenji Ito, Tetsuhiko Yasuno, Shigeaki Mukobara, Daiji Kawanami, Kosuke Masutani, Hisatomi Arima Published: 2026 ABSTRACT AbstractThe present study examined the association between alcohol consumption and hyperuricemia in Japanese men and women. This is a population-based retrospective cohort study (ISSA-CKD study). A total of 5153 participants without hyperuricemia were followed up from baseline (first health check-up of each participant) to the last visit during the study period (2008–2019). Alcohol consumption was classified into non-drinkers, occasional, and daily drinkers (average alcohol intake < 22 g/day, 22–43 g/day, 44–65 g/day, or ≥ 66 g/day). The outcome was incident hyperuricemia (uric acid > 416 μmol/L [7.0 mg/dL]). During average follow-up of 5.5 years, 496 men and 128 women developed new-onset hyperuricemia. Increases in the incidence (per 1,000 person-years) of hyperuricemia were associated with the frequency/amount of alcohol consumed among men (non-drinkers: 33.7, occasional: 43.9, daily (< 22 g/day): 41.7, daily 22–43 g/day: 60.6, daily 44–65 g/day: 68.0, and daily ≥ 66 g/day: 92.7; P < 0.001). Similar results were observed in women (non-drinkers: 6.1, occasional: 10.3, daily (< 22 g/day): 8.8, daily(≥ 22 g/day): 13.4; P = 0.0051). After multivariable adjustment, hazard ratios increased with higher alcohol consumption in both men and women. In conclusion, alcohol consumption was associated with an increased risk of hyperuricemia in each sex. Even low or occasional intake elevated the risk, indicating no safe level of alcohol consumption.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-46480-3.Subject terms: Health care, Nephrology Introduction Hyperuricemia is a high-risk condition for gouty arthritis due to urate deposition as well as ureteral stones1. Hyperuricemia has also been associated with cardiovascular risk factors, such as obesity2, hypertension3, diabetes4, metabolic syndrome5, and chronic kidney disease (CKD)6. To prevent hyperuricemia and subsequent health-related issues, strategies based on up-to-date information on predictors of hyperuricemia are needed. For healthier eating patterns and minimization of the risks associated with alcohol consumption, the Dietary Guidelines for Americans recommends that adults do not drink or limit their alcohol intake to 28 g/day or less for men and 14 g/day or less women on days when alcohol is consumed7. In addition, the Global Burden of Disease Study 2016 reported an increased risk of various diseases with low alcohol consumption, suggesting that no level of alcohol consumption is safe for our health8. Current evidence on the relationship between the amount of alcohol consumed and hyperuricemia is mainly derived from cross-sectional studies9–13 and the number of prospective studies is limited. Most prior longitudinal studies included worksite-based populations14–17 and number of the population-based longitudinal studies is very limited in Japan as well as in other countries in the world. Furthermore, longitudinal associations between alcohol intake and incidence of hyperuricemia has not clearly defined among women, because a longitudinal study did not involve female participants11 and some longitudinal studies failed to show separately significant associations between alcohol intake and uric acid among women10,12,18. Therefore, the aim of this study was to examine the longitudinal association between alcohol intake and the incidence of hyperuricemia in a Japanese population, evaluating both men and women separately. Methods Research design and participants The Iki City Epidemiological Study of Atherosclerosis and Chronic Kidney Disease (ISSA-CKD) study is a retrospective cohort study on residents of Iki city, Japan. The study design has been described in detail in previous studies19–26. Iki city (approximately 26,000 residents) is on an island in the northern part of Nagasaki Prefecture. A total of 8,024 residents (≥ 30 years old) who underwent a health examination conducted annually by Iki city at least once between 2008 and 2019 were eligible for inclusion in the present study. After the exclusion of 1,902 individuals with < 1-year follow-up, 545 with hyperuricemia at baseline, and 424 with missing information on alcohol consumption, 5,153 residents (2,142 men and 3,011 women) were included in the analysis (Fig. 1). The opt-out approach was used to obtain informed consent from participants, and this study was approved by the Fukuoka University Medical Ethics Review Board (No.2017M010). Informed consent of was obtained using opt-out approach approved by the institutional ethics committee. Participants were informed about the study through publicly available information, and those who did not decline participation were considered to have provided consent. The study was conducted in accordance with the principles of the Declaration of Helsinki and the Ethical Principles for Medical Research and Ethical Guidelines for Medical and Biological Research Involving Human Subjects of the Japanese government. Flow diagram of participants. HUA: serum uric acid > 7 mg/dL (0.42 mmol/l). HUA, hyperuricemia. Data collection At each health examination visit, alcohol consumption was assessed using a questionnaire developed for the national “Standard Medical Examination and Health Guidance Program” issued by the Ministry of Health, Labour and Welfare of Japan27, which is widely used in routine health examinations across Japan. The first question was “frequency of alcohol (sake, shochu, beer, distilled spirits etc.) intake”. Participants reported their drinking frequency for various types of alcoholic beverages, including sake, shochu, beer, distilled spirits etc., with the response options: daily, occasionally, or rarely/never. The second question was “the amount of alcohol consumed on drinking days”. One “go” of sake (180 mL) was used as the reference unit, which corresponds approximately to one medium bottle of beer (500 mL), 80 mL of 35% shochu, a double shot of whiskey (60 mL), or two glasses of wine (240 mL). Participants selected from the following categories for their daily alcohol consumption: less than 1 go, 1 to less than 2 go, 2 to less than 3 go, or 3 go or more. One “go” of sake contains approximately 22 g of pure alcohol. Finally, current daily drinkers were classified into the following categories: < 22 g/day, 22–43 g/day, 44–65 g/day and ≥ 66 g/day among men; < 22 g/day and ≥ 22 g/day among women. A standard questionnaire was also used to obtain information on smoking habits and regular exercise at baseline. Smoking habits were classified into current smoking (regular smoking for ≥ 6 months) or not, and exercise habits into regular exercise (≥ 30 min/day and ≥ twice/week) or not. Body mass index (BMI, kg/m2) was calculated as body weight (kg)/height (m)2, with BMI ≥ 25 kg/m2 being regarded as obese28. After at least 5 min of rest in a sitting position, blood pressure (BP) was measured twice using a mercury, aneroid, or automated sphygmomanometer with a cuff (appropriate size) on the right upper arm. The mean of 2 BP values was used in the present study. Hypertension was defined as a systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, or the use of antihypertensive medication, in accordance with the guidelines of the Japanese Society of Hypertension. At the time of data collection, this threshold was the standard diagnostic criterion for hypertension in Japan29. At each visit, casual blood and urine samples were collected. Serum uric acid levels were measured using an enzymatic method. High-performance liquid chromatography was used to assess glycated hemoglobin (HbA1c) levels (NGSP value). An enzymatic method was performed to measure plasma glucose concentrations. HbA1c ≥ 6.5%, fasting glucose ≥ 7.0 mmol/L, non-fasting glucose ≥ 11.1 mmol/L, or the use of glucose-lowering therapies was regarded as diabetes30. Serum triglyceride, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol levels were measured using an enzymatic method. LDL cholesterol ≥ 3.62 mmol/l, HDL cholesterol < 1.03 mmol/l, triglycerides ≥ 1.69 mmol/l, or the use of lipid-lowering medication was regarded as dyslipidemia. An enzymatic method was used to measure serum creatinine concentrations. The estimated glomerular filtration rate (eGFR) was calculated as: eGFR (mL/min/1.73 m2) = 194 × serum creatinine (mg/dL)-1.094 × age-0.287 (× 0.739 if female)31. Urinary protein levels were measured using the dipstick method. Proteinuria was defined as a score of 1 + or higher. eGFR < 60 mL/min/1.73 m2 and/or proteinuria was regarded as CKD. Definition of the outcomes During the study period (2008–2019), the first health check-up by each participant was defined as baseline. In each follow-up examination, casual blood samples were obtained and serum uric acid levels were measured using an enzymatic method. Participants were followed up until the most recent health check-up. The primary outcome was the incidence of hyperuricemia (uric acid level > 7.0 mg/dL [416 μmol/L])32 during the follow-up period. Statistical analysis Continuous variables are shown as the mean ± SD. Differences across alcohol consumption groups were tested using a simple regression model. Categorical variables are shown as N (percentage). Differences across alcohol consumption groups were tested using a logistic regression model. The incidence of hyperuricemia was calculated in the total population and in alcohol consumption groups using the person-year approach. The relationship between the incidence of hyperuricemia and alcohol consumption was evaluated using Cox proportional hazards models including age, smoking, regular exercise, hypertension, diabetes, dyslipidemia, and chronic kidney disease as covariates. The proportional hazards assumption was assessed using Schoenfeld residuals and corresponding statistical tests. In addition, graphical evaluation was performed using log–log survival plots33. Differences in the effects of alcohol consumption on the incidence of hyperuricemia were compared between men and women by adding interaction terms to the statistical models. A P value < 0.05 was significant. SAS version 9.4 was used for statistical analyses. Results Table 1 shows the baseline characteristics of men according to alcohol consumption groups. Men with higher intakes of alcohol were more likely to be current smokers and had higher levels of BP, HDL cholesterol, LDL cholesterol, triglycerides, and uric acid. Table 1Baseline characteristics of men according to alcohol consumption groups.Alcohol consumptionP value for trendNo(N = 598)Occasional(N = 604)Daily volume < 22 g/day(N = 293)22–43 g/day(N = 464)44–65 g/day(N = 138) ≥ 66 g/day(N = 45)Age, mean (SD), years60.3(11.0)58.8(11.1)63.4(7.7)60.7(9.2)57.2(10.9)54.4(9.8)0.249Smoking, N (%)184(30.8)204(33.8)85(29.0)183(39.4)67(48.6)21(46.7) < 0.001Regular exercise*, N (%)166(28.0)198(33.0)91(31.3)120(26.1)36(26.3)10(22.2)0.162Physical activity, N (%)257(43.0)295(48.8)153(52.2)208(44.8)61(44.5)21(46.7)0.639Body mass index, mean (SD) ,kg/m223.8(3.4)23.8(3.3)23.6(2.8)24(3.1)23.9(2.9)23.8(3.0)0.470Obesity**, N (%)214(35.8)191(31.6)89(30.4)146(31.5)48(34.8)12(26.7)0.193Systolic blood pressure, mean (SD) ,mmHg127.8(18.1)128.4(18.0)132.9(17.9)134.6(17.3)133.7(18.5)132.6(18.2) < 0.001Diastolic blood pressure, mean (SD), mmHg74.6(10.8)75.7(11.4)76.5(11.3)78.4(10.4)79.6(11.2)78.8(11.5) < 0.001Hypertension***, N (%)252(42.1)252(41.7)154(52.6)268(57.8)82(59.4)20(44.4) < 0.001HbAlc, mean (SD), %5.3(0.9)5.3(0.7)5.2(0.6)5.2(0.8)5.3(1.0)5.2(0.7)0.147Diabetes mellitus****, N (%)80(13.4)65(10.8)31(10.6)55(11.9)24(17.4)2(4.4)0.808HDL cholesterol, mean (SD), mmol/L52.7(13.4)57.2(15.0)60.3(16.8)62.1(15.2)63.4(15.4)71(18.7) < 0.001LDL cholesterol, mean (SD), mmol/L119.5(29.7)118.9(31.0)114.830.7112.2(29.1)112.7(30.4)116.6(29.0) < 0.001Triglycerides, mean (SD), mmol/L120(64.2)122.2(73.9)121.9(97.1)126.1(97.1)137.9(110.2)156.7(119.5)0.004Dyslipidemia*****, N (%)280(46.8)245(40.6)116(39.6)163(35.1)57(41.3)22(48.9)0.010Serum creatinine, mean (SD), mg/dL0.9(0.5)0.8(0.1)0.8(0.1)0.8(0.1)0.9(0.9)0.8(0.1)0.034Estimated glomerular filtration rate, mean (SD),mL/min/1.73 m274.3(16.2)77.4(15.5)75.9(12.7)78.8(13.8)78.6(16.1)83.2(17.4) < 0.001Uric acid, mean (SD), mg/dL5.3(1.0)5.5(0.9)5.5(0.9)5.6(0.9)5.6(0.9)5.9(0.8) < 0.001Urine protein, N (%)50(8.4)48(8.0)16(5.5)26(5.6)8(5.8)3(6.7)0.049Chronic kidney disease, N (%)******123(20.6)99(16.5)42(14.3)56(12.1)16(11.6)6(13.3)0.106*Exercise habit ≥ 30 min per day twice or more per week.**Body mass index ≥ 25 kg/m.***BP ≥ 140/90 mmHg or use of blood pressure-lowering medication.****Fasting blood glucose concentration ≥ 7.0 mmol/L, Non -fasting blood glucose concentration ≥ 11.1 mmol/L, HbA1c value≥ 6.5%, or the use of glucose-lowering therapy.*****LDL cholesterol concentration ≥ 3.62 mmol/L, HDL cholesterol concentration < 1.03 mmol/L, triglyceride concentration ≥ 1.69 mmol/L, or use of lipid-lowering medication.******eGFR < 60 mL/min/1.73 m2 or urine protein≥ 1. Baseline characteristics of men according to alcohol consumption groups. *Exercise habit ≥ 30 min per day twice or more per week.**Body mass index ≥ 25 kg/m.***BP ≥ 140/90 mmHg or use of blood pressure-lowering medication.****Fasting blood glucose concentration ≥ 7.0 mmol/L, Non -fasting blood glucose concentration ≥ 11.1 mmol/L, HbA1c value≥ 6.5%, or the use of glucose-lowering therapy.*****LDL cholesterol concentration ≥ 3.62 mmol/L, HDL cholesterol concentration < 1.03 mmol/L, triglyceride concentration ≥ 1.69 mmol/L, or use of lipid-lowering medication.******eGFR < 60 mL/min/1.73 m2 or urine protein≥ 1. Table 2 shows the baseline characteristics of women according to alcohol consumption groups. Women with higher intakes of alcohol were younger, more likely to be current smokers, had lower levels of BMI, HbA1c, LDL cholesterol, and triglycerides, and had higher levels of HDL cholesterol and uric acid. Table 2Baseline characteristics of women according to alcohol consumption groups.Alcohol consumptionp value for trendNoN = 2271OccasionalN = 584Daily volume <22 g/day(N = 79) ≥ 22 g/day(N = 77)Age, mean (SD), years61.6(9.6)56.6(11.1)56.4(11.3)52.8(10.7) < 0.001Smoking, N (%)112(4.9)53(9.1)15(19.0)30(39.0) < 0.001Regular exercise*, N (%)575(25.8)138(23.4)55(69.6)59(79.7)0.421Physical activity, N (%)1053(46.4)243(41.6)30(38.0)33(42.9)0.036Body mass index, mean (SD) ,kg/m223.5(3.7)23.4(3.5)21.7(2.6)22.5(3.4) < 0.001Obesity**, N (%)678(29.9)170(29.1)7(8.9)15(19.5)0.001Systolic blood pressure, mean (SD) ,mmHg128.9(18.9)126.2(19.8)126(20.5)128.3(19.3)0.023Diastolic blood pressure, mean (SD), mmHg73.6(10.7)73.2(11.0)73.5(11.8)74.9(12.3)0.860Hypertension***, N (%)990(43.6)217(37.2)29(36.7)33(42.9)0.042HbAlc, mean (SD), %5.2(0.7)5.2(0.6)5.1(0.5)5(0.6) < 0.001Diabetes mellitus****, N (%)169(7.4)26(4.5)1(1.3)3(3.9)0.003HDL cholesterol, mean (SD), mmol/L64(15.3)67.9(16.9)70.1(13.9)77.6(22.5) < 0.001LDL cholesterol, mean (SD), mmol/L128.2(31.7)125(32.5)124.7(32.5)111.2(33.8) < 0.001Triglycerides, mean (SD), mmol/L109.4(61.2)103.9(70.7)98.5(62.7)104.4(67.1)0.039Dyslipidemia*****, N (%)1003(44.2)225(38.5)25(31.7)21(27.3) < 0.001Serum creatinine, mean (SD), mg/dL0.6(0.1)0.6(0.1)0.7(0.1)0.6(0.1)0.369Estimated glomerular filtration rate, mean (SD),mL/min/1.73 m273.7(14.5)76(14.9)73(12.1)78.8(14.7) < 0.001Uric acid, mean (SD), mg/dL4.4(1.0)4.5(1.0)4.6(1.0)4.6(1.0) < 0.001Urine protein, N (%)73(3.2)22(3.8)3(3.8)5(6.5)0.140Chronic kidney disease, N (%)******349(15.4)78(13.4)9(11.4)9(11.7)0.098Exercise habit ≥30 min per day twice or more per week.**Body mass index ≥25 kg/m.***BP≥140/90 mmHg or use of blood pressure-lowering medication.****Fasting blood glucose concentration ≥7.0 mmol/L, Non‐fasting blood glucose concentration ≥ 11.1 mmol/L, HbAlc value ≥6.5%, or the use of glucose-lowering therapy.*****LDL cholesterol concentration ≥3.62 mmol/L, HDL cholesterol concentration < 1.03 mmol/L, triglyceride concentration ≥1.69 mmol/L, or use of lipid-lowering medication.******eGFR < 60 mL/min/1.73 m2 or urine protein ≥1. Baseline characteristics of women according to alcohol consumption groups. Exercise habit ≥30 min per day twice or more per week.**Body mass index ≥25 kg/m.***BP≥140/90 mmHg or use of blood pressure-lowering medication.****Fasting blood glucose concentration ≥7.0 mmol/L, Non‐fasting blood glucose concentration ≥ 11.1 mmol/L, HbAlc value ≥6.5%, or the use of glucose-lowering therapy.*****LDL cholesterol concentration ≥3.62 mmol/L, HDL cholesterol concentration < 1.03 mmol/L, triglyceride concentration ≥1.69 mmol/L, or use of lipid-lowering medication.******eGFR < 60 mL/min/1.73 m2 or urine protein ≥1. A total of 5,153 participants were followed up for an average of 5.498351 year (a total of 28,3333 person-years of follow-up) (average 4.5 follow-up visits), 624 participants (496men and 128 women) developed incident hyperuricemia during the follow-up period. Table 3 shows the risk of hyperuricemia in men according to alcohol consumption groups. Increases in the incidence (per 1,000 person-years) of hyperuricemia were associated with the frequency/amount of alcohol consumed among men: 33.7 for non-drinkers, 43.9 for occasional drinkers, 41.7 for daily drinkers (< 22 g/day), 60.6 for daily drinkers (22–43 g/day), 68.0 for daily drinkers (44–65 g/day), and 92.7 for daily drinkers (≥ 66 g/day) (P < 0.001 for trend). This association remained after adjustment for potential confounding factors. Compared with non-drinkers, occasional drinkers had an increased risk of hyperuricemia (HR 1.36, 95% CI 1.04–1.76), as did daily drinkers consuming < 22 g/day (HR 1.27, 95% CI 0.93–1.74), 22–43 g/day (HR 1.87, 95% CI 1.44–2.43), 44–65 g/day (HR 2.07, 95% CI 1.45–2.96), and ≥ 66 g/day (HR 3.13, 95% CI 1.91–5.16), with a positive dose–response trend (trend test P < 0.001). The 95% CI for the < 22 g/day category included 1.0. No evidence of violation of the proportional hazards assumption was observed based on the Schoenfeld residual tests and graphical inspection of the log–log survival plots. Table 3Risk of hyperuricemia in men according to alcohol consumption groups.Alcohol consumptionp valuefor trendNoN = 598OccasionalN = 604Daily volume < 22 g/dayN = 29322-43 g/dayN = 46444-65 g/dayN = 138 ≥ 66 g/dayN = 45N of events/person-years100/2971129/293765/1558138/227645/114219/205Incidence (per 1000person-years)33.743.941.760.668.092.7Crude hazard ratio1.001.291.261.822.042.76 < 0.001(95% confidence interval)Reference0.99–1.680.92–1.721.41–2.351.44–2.901.69–4.51Adjusted hazard ratio*1.001.361.271.872.073.13 < 0.001(95% confidence interval)Reference1.04–1.760.93–1.741.44–2.431.45–2.961.91–5.16* Adjusted for age, smoking, regular exercise, hypertension, diabetes, dyslipidemia, and chronic kidney disease. Risk of hyperuricemia in men according to alcohol consumption groups. * Adjusted for age, smoking, regular exercise, hypertension, diabetes, dyslipidemia, and chronic kidney disease. Table 4 shows the risk of hyperuricemia in women according to alcohol consumption group. The incidence rate (per 1,000 person-years) increased with greater alcohol consumption: 6.1 for non-drinkers, 10.3 for occasional drinkers, 8.8 for daily drinkers (< 22 g/day), and 13.4 for daily drinkers (≥ 22 g/day) (trend test P = 0.0051). Table 4Risk of hyperuriemia in women according to alcohol consumption groupsAlcohol consumptionp valuefor trendNoN = 2271OccasionalN = 584Daily volume < 22 g/dayN = 79≥ 22 g/dayN = 77N of events/person-years81/1323837/35834/4556/448Incidence (per 1000person-years)6.110.38.813.4Crude hazard ratio1.001.711.432.170.0051(95% confidence interval)Reference1.16–2.520.53–3.910.95–4.96Adjusted hazard ratio*1.002.052.232.92 < 0.001(95% confidence interval)Reference1.38-3.040.81-6.171.22-6.99Adjusted for age, smoking, regular exercise, hypertension, diabetes, dyslipidemia, and chronic kidney disease. Risk of hyperuriemia in women according to alcohol consumption groups Adjusted for age, smoking, regular exercise, hypertension, diabetes, dyslipidemia, and chronic kidney disease. After multivariable adjustment, occasional drinkers had approximately a twofold higher risk of hyperuricemia compared with non-drinkers (HR 2.05, 95% CI 1.38–3.04). Women consuming ≥ 22 g/day also showed a higher risk (HR 2.92, 95% CI 1.22–6.99). In contrast, the estimate for women consuming < 22 g/day was less precise, as reflected by the wide confidence interval that included the null value (HR 2.23, 95% CI 0.81–6.17). The overall trend across alcohol consumption categories remained positive (trend test P < 0.001). However, the number of women who reported daily alcohol consumption was 150 (5.19% of all female participants). No evidence of violation of the proportional hazards assumption was observed based on the Schoenfeld residual tests and graphical inspection of the log–log survival plots33. The interaction between alcohol consumption and sex was not statistically significant (P for interaction = 0.309). As a sensitivity analysis, we reclassified men using the same four alcohol consumption categories as women (non-drinkers, occasional drinkers, < 22 g/day, and ≥ 22 g/day) to facilitate direct comparison by sex. The association between alcohol consumption and incident hyperuricemia remained positive, and the results were consistent with the primary analysis (Supplementary Table 1). Discussion In the present observational study on the general Japanese population, an increased intake of alcohol was associated with a higher risk of developing hyperuricemia in the future in both men and women. The risks of hyperuricemia started to increase from occasional drinkers or daily alcohol drinkers with small alcohol consumption (< 22 g/day)34. The positive association persisted after adjustment for age, smoking, regular exercise, hypertension, diabetes, and dyslipidemia, with hazard ratios remaining above 1.0 and confidence intervals excluding unity in most alcohol consumption categories. The magnitude of the association between alcohol consumption and incident hyperuricemia was comparable between men and women, and the confidence intervals of sex-specific estimates largely overlapped, suggesting no strong evidence of effect modification by sex. Previous studies examined the relationship between alcohol consumption and hyperuricemia in men. A few longitudinal studies (4 worksite-based14–17) reported this relationship in Japan. A worksite-based study on 3,310 Japanese men found a dose-dependent relationship: HR 1.10 for male drinkers who consumed < 16.4 g/day of alcohol, 1.40 for 1.46–32.7 g/day, 1.64 for 32.9–49.1 g/day, and 1.98 for ≥ 49.2 g/day relative to non-drinkers17. A population-based study on 3,188 Japanese men (The Circulatory Risk in Communities Study: CIRCUS) also noted a dose-dependent relationship: HR 1.22 for male drinkers who consumed < 46 g/day of alcohol and 1.44 for ≥ 46 g/day relative to non-drinkers18. The present study on general Japanese men confirmed the findings from previous observational studies which demonstrated dose-dependent association between volume of daily alcohol consumption and the risks of hyperuricemia, and clearly demonstrated that increases in the incidence of hyperuricemia were associated with the amount of alcohol consumed, with modest increase in risk from occasional drinkers and the highest risk being observed in men consuming ≥ 66 g of alcohol every day. There has been limited longitudinal evidence on the relationship between alcohol consumption and the incidence of hyperuricemia in women. A population-based study on 6,346 Japanese women (CIRCUS) reported no clear relationship between alcohol consumption and the incidence of hyperuricemia18. HR for the development of hyperuricemia was 1.02 among female drinkers consuming < 46 g/day of alcohol relative to non-drinkers; however, the number of participants who developed hyperuricemia was small (only 33 events). Furthermore, there were very few female drinkers consuming ≥ 46 g/day of alcohol and no data were available for them. This study suggests that the risk of future hyperuricemia in women begins to increase among occasional drinkers and/or daily drinkers with low alcohol intake and increases among daily drinkers with moderate alcohol intake (≥ 22 g/day). However, because the number of women who reported daily alcohol consumption was relatively small, the estimates in this subgroup may be less precise. Future large-scale research is required to clarify the possible dose-dependent relationship between the amount of alcohol consumed and the incidence of hyperuricemia. The mechanisms underlying the relationship between alcohol consumption and hyperuricemia involve (1) high levels of purines in alcoholic beverages35,36, (2) the increased breakdown of nucleotides and another source of purines that may be converted into uric acid (e.g. the excessive ATP associated metabolism has been shown to increase the degeneration of adenine nucleotides)37, and (3) a reduction in uric acid excretion (e.g. hyperlactatemia, which is associated with heavy drinking, has been shown to accelerate the reabsorption of uric acid when lactic acid is excreted in the urine via urate transporter 1 in the proximal tubules)38. Although this was a large-scale longitudinal study on the general Japanese population, it has several limitations. Since the study design is retrospective, the results obtained may have been affected by a survivor bias. Furthermore, this study recruited individuals who voluntarily underwent health examinations and, thus, were more likely to be aware of healthy lifestyle habits than those who did not undergo a health examination. Therefore, findings of this study may have been affected by a selection bias. Moreover, accuracy in the self-reporting of alcohol consumption may be limited. Underreporting of alcohol consumption among current drinkers who consume a lot of alcohol may have contributed to an underestimation of the association between alcohol intake and incidence of hyperuricemia. In addition, although we adjusted for several established confounders, the possibility of residual or unmeasured confounding cannot be excluded. Factors such as dietary habits, socioeconomic status, or other lifestyle behaviors not assessed in this study may have influenced the association between alcohol consumption and the incidence of hyperuricemia. Additionally, alcohol intake was assessed only at baseline. Since the Cox proportional hazards model used baseline alcohol intake, changes in drinking habits during follow-up were not captured. This may have introduced classification errors in exposure over time, potentially weakening the observed association. Another limitation is that, among women, daily alcohol consumption was categorized into only 2 groups (less than 22 g/day and 22 g/day or more) because of very small sample sizes and event numbers among female current daily drinkers with daily alcohol volume of 44 g/day or more. Another limitation is that lack of information on the types of alcohol consumed in this study. In addition, information on the use of hyperuricemia medications was not available. Finally, incomplete attendance at follow-up visits may also have influenced the results although the average number of follow-up visits was 4.5 during an average follow-up of approximately 5.5 years, suggesting many participants visited annually. In addition, hypertension was defined as blood pressure ≥ 140/90 mmHg or the use of antihypertensive medication, in accordance with the guidelines of the Japanese Society of Hypertension29 at the time of data collection. We acknowledge that alternative diagnostic thresholds for hypertension have been proposed, including ≥ 130/80 mmHg in certain international guidelines. However, the Japanese guidelines maintain the diagnostic criterion of office blood pressure ≥ 140/90 mmHg, while recommending a treatment target of < 130/80 mmHg for adults under 75 years of age. Therefore, differences in diagnostic criteria may limit direct comparability with studies using alternative definitions. Conclusion In this longitudinal study of Japanese men and women, alcohol consumption was associated with an increased risk of developing hyperuricemia in both men and women. Even low or occasional alcohol intake elevated the risk within each sex, indicating that no level of alcohol consumption can be considered completely safe for preventing hyperuricemia among men or women. Supplementary Information Supplementary Information. Acknowledgements We sincerely appreciate residents and the local government of the Iki City, Nagasaki, Japan. Author contributions Conceptualization, H.A. and T.U.; date curation, H.A.; formal analysis, T.M. and H.A.; investigation, K.K., C.N., Kaori M., Kazuyo I., A.M., S.F., M.A., A.S., M.K., C.Y., Koji T., Kazuhiro T., Kenji I., T.Y., S.M., D.K., Kosuke M. and T.U.; methodology, H.A.; project administration, H.A.; software, H.A.; supervision, H.A.; Writing-original draft., T.U. and H.A.; Writing-review and editing, Kosuke M., D.K., A.M., T.Y., and T.U. All authors were informed about each step of manuscript processing including the submission, revision, revision reminder, etc. Data availability The datasets generated during and/or analyzed during the current study are not publicly available for ethical reasons. The data for this study was provided by the Iki Health Center in Nagasaki Prefecture, and the authors do not have the right to share this data. Their publication would be in violation of the Act on the Protection of Personal Information of the Japanese government but are available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Information. Data Availability Statement The datasets generated during and/or analyzed during the current study are not publicly available for ethical reasons. The data for this study was provided by the Iki Health Center in Nagasaki Prefecture, and the authors do not have the right to share this data. Their publication would be in violation of the Act on the Protection of Personal Information of the Japanese government but are available from the corresponding author on reasonable request.